BioXcel Therapeutics Inc (FRA:BX20)
€ 0.72 -0.062 (-7.93%) Market Cap: 24.06 Mil Enterprise Value: 97.04 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

BioXcel Therapeutics Inc To Host Virtual Roundtable with Leading Medical Experts Transcript

Dec 08, 2025 / 03:00PM GMT
Release Date Price: €1.77 (+1.72%)
Vimal Mehta
BioXcel Therapeutics Inc - President, Chief Executive Officer, Director

Good morning, everyone, and thank you for joining us today. I would like to start by welcoming our distinguished participants. We are grateful to each of you for bringing your deep experience in the agitation space to help us shape this important discussion. Your insights are essential as we continue working to improve care for the millions of patients and families managing acute agitation associated with schizophrenia and bipolar disorders in the home setting.

I would also like to thank our moderator, Anjalee Khemlani, an award-winning journalist known for her thoughtful and in-depth reporting on healthcare. We are delighted to have a guide to this conversation and introduce the clinical experts who will be sharing their perspective.

And episodes of acute agitation remain a significant challenge, especially for those navigating them outside clinical environment. The need for practical patient-centered innovation has never been clearer. Today's roundtable reflects our commitment to advancing solutions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot